.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Doxorubicin, Interleukin-12 Join Against KS

June 1, 2003

Boston - Combined cytotoxic and antiangiogenic therapies may have synergistic effects in treating advanced Kaposi's sarcoma in patients with AIDS, according to Richard F. Little, M.P.H., M.D., senior clinical investigator, HIV and AIDS malignancy branch, Center for Cancer Research, National Cancer Institute.